Outlook Therapeutics (OTLK) Current Deferred Revenue (2015 - 2019)
Outlook Therapeutics (OTLK) reported Current Deferred Revenue of $2.34 million for fiscal Q3 2019 (quarter ended Jun 30, 2019), up 5.8% from $2.21 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Current Deferred Revenue (2015 - 2019) Analysis & Trends
At the end of FY2018 (ended Sep 30, 2018), Outlook Therapeutics posted Current Deferred Revenue of $1.74 million, down 43.7% from FY2017.
- Current Deferred Revenue has a three-year compound annual growth rate of -4.2% (FY2015 to FY2018).
- By fiscal year, Current Deferred Revenue came in at $3.09 million in FY2017 (+154.6%), $1.21 million in FY2016 (-38.7%) and $1.98 million in FY2015.
- Five-year quarterly Current Deferred Revenue spans a low of $1.21 million in fiscal Q4 2016 and a high of $3.09 million in fiscal Q4 2017.
- Year over year, Current Deferred Revenue gained in five of the last eight quarters, with growth averaging 52.6%.
- The high point for year-over-year Current Deferred Revenue in five years was fiscal Q4 2017 (growth of 154.6%); the low point was fiscal Q4 2018 (a decline of 43.7%).
- Per Business Quant data, the three fiscal quarters before Q3 2019 came in at $2.34 million (Q2 2019), $2.39 million (Q1 2019) and $1.74 million (Q4 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 2.34 Mn |
| Mar 31, 2019 | 2.34 Mn |
| Dec 31, 2018 | 2.39 Mn |
| Sep 30, 2018 | 1.74 Mn |
| Jun 30, 2018 | 2.21 Mn |
| Mar 31, 2018 | 2.68 Mn |
| Dec 31, 2017 | 2.75 Mn |
| Sep 30, 2017 | 3.09 Mn |
| Jun 30, 2017 | 1.21 Mn |
| Mar 31, 2017 | 1.21 Mn |
| Dec 31, 2016 | 1.21 Mn |
| Sep 30, 2016 | 1.21 Mn |
| Jun 30, 2016 | 1.98 Mn |
| Mar 31, 2016 | 1.98 Mn |
| Sep 30, 2015 | 1.98 Mn |
API Access
Outlook Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();